325
Participants
Start Date
January 31, 2007
Study Completion Date
December 31, 2009
Rheopheresis
8 rheopheresis treatments over 10 wks.
Rheopheresis
Sham treatment
Macula Care, New York
Vitreous Retina Macula Consultants, New York
Columbia University, New York
Ophthalmic Consultants of Long Island, Lynbrook
University of Pennsylvannia Medical Center, Philadelphia
Retina Group of Washington, Chevy Chase
Fairfax Pathology Associates, Ltd., Annadale
Retina Group of Washington, Fairfax
DSI, Brandon
Center for Retina and Macular Disease, Winter Haven
Retina Associates of Cleveland, Lakewood
Retina Associates of Cleveland, Beachwood
Cleveland Clinic Foundation, Cole Eye Institute, Cleveland
The Cleveland Clinic, Cleveland
University of Illinois at Chicago, Chicago
University of Chicago, Chicago
Texas Retina Associates, Dallas
Memorial Hermann University of Texas Health Science Center, Houston
The Methodist Hospital System, Houston
Vitreoretinal Consultants, Houston
Retinal Consultants of Arizona, Phoenix
Associated Retina Consultants, LTD., Phoenix
Mayo Clinic Hospital, Phoenix
Mayo Clinic, Department of Ophthalmology, Scottsdale
Southwest Kidney Institute, PLC, 2149 East Warner Rd. Ste. 109 & 110, Tempe
Good Samaritan Hospital, Los Angeles
Retina-Vitreous Associates Medical Group, Beverly Hills
University of Illinois at Chicago, Chicago
Vitreo-Retinal Associates, Worcester
University of Massachuesettes Medical Health Center, Worcester
Retinovitreous Associates, Ltd., Cherry Hill
New York Blood Center, New York
UT Southwestern Medical Center, Dallas
Capital Health Systems, Ophthalmology & Visual Sciences, Halifax
Victoria General Hospital, Halifax
eyeMD Institute, Brampton
Dr. Sapir, Oakville
Rheopheresis Center Cologne, Cologne
University of Cologne, Cologne
Lead Sponsor
OccuLogix
INDUSTRY